XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 1,489,444 $ 884,377
Investments held in marketable securities 11,598,417 10,181,618
Accounts receivable 165,000 19,300
Prepaid expenses and other current assets 233,697 305,231
Deferred offering costs 22,381
Total Current Assets 13,508,939 11,390,526
Property and equipment, net 378,434 356,055
Right-of-use assets 39,697 151,447
Intangible assets, net 646,381 713,692
Total Assets 14,573,451 12,611,720
Current Liabilities:    
Accounts payable 401,379 189,389
Accrued expenses and other current liabilities 682,237 711,686
Lease liability 42,414 162,317
Warrant liabilities 3,455,505 1,543,953
Total Current Liabilities 4,581,535 2,607,345
Total Liabilities 4,581,535 2,607,345
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 1,398,158 shares issued and outstanding at September 30, 2024 and December 31, 2023 13,982 13,982
Common stock, $0.0001 par value; 75,000,000 shares authorized; 6,919,919 and 4,706,917 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 692 471
Additional paid-in capital 164,019,809 156,689,256
Accumulated deficit (154,042,567) (146,699,334)
Total Stockholders’ Equity 9,991,916 10,004,375
Total Liabilities and Stockholders’ Equity $ 14,573,451 $ 12,611,720